[关于在接受胃肠内镜检查的患者中使用抗血栓剂的IDEN共识]
Seung Joo Kang1, Chung Hyun Tae2, Chang Seok Bang3
1Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.
概括
本指南提供了更新的建议,用于在内镜手术期间管理服用抗血栓剂的患者. 它解决了关于双重抗血小板治疗和抗凝固剂的新证据,以确保更安全的患者护理.
科学领域:
- 胃肠病学和心脏病学
- 临床实践指南 临床实践指南
背景情况:
- 由于心脑血管疾病的增加和人口老龄化,韩国越来越多地使用抗血栓剂.
- 在内镜手术期间使用这些药物的患者的管理是一个临床挑战.
- 2020年以前的指导方针需要更新,因为新的证据和国际修订.
研究的目的:
- 修订和更新临床实践指南,用于管理接受内镜检查的抗血栓治疗患者.
- 纳入最近关于双重抗血小板治疗和直接抗凝药的证据.
- 为内镜医生提供基于证据的建议.
主要方法:
- 根据新的证据,对现有指南进行修订.
- 将心脏病学家和国际专家纳入开发小组.
- 建议分级,评估,开发和评价 (GRADE) 方法的应用.
- 多学科专家之间的共识过程.
主要成果:
- 制定14个修订后的建议.
- 由多学科专家审查的指南.
- 为治疗抗血栓剂患者的内镜医生提供可操作的信息.
结论:
- 修订后的指南有助于内镜医生在诊断和治疗内镜期间管理服用抗血栓剂的患者.
- 它结合了最新的证据和专家的共识.
- 该指南将随着新证据的出现而更新.
相关概念视频
Peptic Ulcer Disease IV: Management
87
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
87
Endoscopic Procedures I: Esophagogastroduodenoscopy
101
An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
During an EGD, the endoscope can be used to:
101
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
517
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
517
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57


